
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $98.7M | $155.7M | $284M | $288.4M | $288.5M | |
Revenue Growth (YoY) | -0.32% | 57.83% | 82.41% | 1.53% | 0.05% | |
Cost of Revenues | $79.6M | $127M | $235.2M | $238.3M | $238.5M | |
Gross Profit | $19.1M | $28.7M | $48.9M | $50.1M | $50M | |
Gross Profit Margin | 19.31% | 18.44% | 17.2% | 17.36% | 17.33% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $17.1M | $21.7M | $37.8M | $37.7M | $39.5M | |
Other Inc / (Exp) | $1.2M | -- | -- | -- | -$5.5M | |
Operating Expenses | $18.3M | $24.2M | $47.5M | $47.2M | $48.9M | |
Operating Income | $750.3K | $4.5M | $1.4M | $2.8M | $1.1M | |
Net Interest Expenses | $701.9K | $2.5M | $7.3M | $9.7M | $10.3M | |
EBT. Incl. Unusual Items | $1.3M | $2M | -$5.9M | -$6.9M | -$14.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $254K | $321.2K | $172.6K | $387K | $291K | |
Net Income to Company | $1M | $1.7M | -$6M | -$7.3M | -$15.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1M | $1.7M | -$6M | -$7.3M | -$15.1M | |
Basic EPS (Cont. Ops) | $0.05 | $0.09 | -$0.31 | -$0.36 | -$0.73 | |
Diluted EPS (Cont. Ops) | $0.05 | $0.08 | -$0.31 | -$0.36 | -$0.73 | |
Weighted Average Basic Share | $16.7M | $18.9M | $19.5M | $20.1M | $20.6M | |
Weighted Average Diluted Share | $16.8M | $20.7M | $19.5M | $20.1M | $20.6M | |
EBITDA | $3.3M | $7.3M | $11.4M | $12.8M | $5.8M | |
EBIT | $2M | $4.5M | $1.4M | $2.8M | -$4.5M | |
Revenue (Reported) | $98.7M | $155.7M | $284M | $288.4M | $288.5M | |
Operating Income (Reported) | $750.3K | $4.5M | $1.4M | $2.8M | $1.1M | |
Operating Income (Adjusted) | $2M | $4.5M | $1.4M | $2.8M | -$4.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $35.1M | $71.5M | $74.1M | $72.7M | $68.4M | |
Revenue Growth (YoY) | 38.57% | 103.76% | 3.62% | -1.97% | -5.81% | |
Cost of Revenues | $28.7M | $60.3M | $61.5M | $58.6M | $57.5M | |
Gross Profit | $6.4M | $11.2M | $12.6M | $14M | $10.9M | |
Gross Profit Margin | 18.35% | 15.73% | 17.04% | 19.32% | 15.97% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.3M | $9.3M | $9.4M | $9.8M | $11.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$6.1M | |
Operating Expenses | $4.7M | $11.7M | $11.8M | $12.2M | $13M | |
Operating Income | $1.8M | -$460.9K | $787.5K | $1.9M | -$2M | |
Net Interest Expenses | $561.5K | $1.6M | $2.4M | $2.5M | $2.3M | |
EBT. Incl. Unusual Items | $1.2M | -$2M | -$1.7M | -$596K | -$10.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $61.8K | $166.8K | $368.5K | $59K | -$22K | |
Net Income to Company | $1.1M | -$2.2M | -$2M | -$655K | -$10.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.1M | -$2.2M | -$2M | -$655K | -$10.4M | |
Basic EPS (Cont. Ops) | $0.06 | -$0.11 | -$0.10 | -$0.03 | -$0.50 | |
Diluted EPS (Cont. Ops) | $0.06 | -$0.11 | -$0.10 | -$0.03 | -$0.50 | |
Weighted Average Basic Share | $18.5M | $19.2M | $19.9M | $20.4M | $20.9M | |
Weighted Average Diluted Share | $19.4M | $19.2M | $19.9M | $20.4M | $20.9M | |
EBITDA | $2.2M | $2M | $3.3M | $4.4M | -$6.4M | |
EBIT | $1.8M | -$460.9K | $787.5K | $1.9M | -$8.2M | |
Revenue (Reported) | $35.1M | $71.5M | $74.1M | $72.7M | $68.4M | |
Operating Income (Reported) | $1.8M | -$460.9K | $787.5K | $1.9M | -$2M | |
Operating Income (Adjusted) | $1.8M | -$460.9K | $787.5K | $1.9M | -$8.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $108.4M | $192.1M | $286.6M | $286.9M | $284.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $87.5M | $158.6M | $236.4M | $235.4M | $237.4M | |
Gross Profit | $21M | $33.5M | $50.2M | $51.5M | $46.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $17M | $26.8M | $37.9M | $38M | $41.2M | |
Other Inc / (Exp) | $1.2M | -- | -- | -- | -$6.1M | |
Operating Expenses | $18.2M | $31.2M | $47.6M | $47.6M | $49.7M | |
Operating Income | $2.7M | $2.3M | $2.7M | $3.9M | -$2.8M | |
Net Interest Expenses | $1.2M | $3.5M | $8.2M | $9.8M | $10.1M | |
EBT. Incl. Unusual Items | $2.8M | -$1.2M | -$5.5M | -$5.8M | -$24.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $368.6K | $426.2K | $374.3K | $77.5K | $209.7K | |
Net Income to Company | $2.4M | -$1.6M | -$5.9M | -$5.9M | -$24.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.4M | -$1.6M | -$5.9M | -$5.9M | -$24.8M | |
Basic EPS (Cont. Ops) | $0.13 | -$0.08 | -$0.30 | -$0.28 | -$1.19 | |
Diluted EPS (Cont. Ops) | $0.13 | -$0.09 | -$0.31 | -$0.28 | -$1.19 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $5.4M | $7M | $12.7M | $13.8M | -$5M | |
EBIT | $4M | $2.3M | $2.7M | $3.9M | -$14.5M | |
Revenue (Reported) | $108.4M | $192.1M | $286.6M | $286.9M | $284.3M | |
Operating Income (Reported) | $2.7M | $2.3M | $2.7M | $3.9M | -$2.8M | |
Operating Income (Adjusted) | $4M | $2.3M | $2.7M | $3.9M | -$14.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $35.1M | $71.5M | $74.1M | $72.7M | $68.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $28.7M | $60.3M | $61.5M | $58.6M | $57.5M | |
Gross Profit | $6.4M | $11.2M | $12.6M | $14M | $10.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.3M | $9.3M | $9.4M | $9.8M | $11.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$6.1M | |
Operating Expenses | $4.7M | $11.7M | $11.8M | $12.2M | $13M | |
Operating Income | $1.8M | -$460.9K | $787.5K | $1.9M | -$2M | |
Net Interest Expenses | $561.5K | $1.6M | $2.4M | $2.5M | $2.3M | |
EBT. Incl. Unusual Items | $1.2M | -$2M | -$1.7M | -$596K | -$10.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $61.8K | $166.8K | $368.5K | $59K | -$22K | |
Net Income to Company | $1.1M | -$2.2M | -$2M | -$655K | -$10.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.1M | -$2.2M | -$2M | -$655K | -$10.4M | |
Basic EPS (Cont. Ops) | $0.06 | -$0.11 | -$0.10 | -$0.03 | -$0.50 | |
Diluted EPS (Cont. Ops) | $0.06 | -$0.11 | -$0.10 | -$0.03 | -$0.50 | |
Weighted Average Basic Share | $18.5M | $19.2M | $19.9M | $20.4M | $20.9M | |
Weighted Average Diluted Share | $19.4M | $19.2M | $19.9M | $20.4M | $20.9M | |
EBITDA | $2.2M | $2M | $3.3M | $4.4M | -$6.4M | |
EBIT | $1.8M | -$460.9K | $787.5K | $1.9M | -$8.2M | |
Revenue (Reported) | $35.1M | $71.5M | $74.1M | $72.7M | $68.4M | |
Operating Income (Reported) | $1.8M | -$460.9K | $787.5K | $1.9M | -$2M | |
Operating Income (Adjusted) | $1.8M | -$460.9K | $787.5K | $1.9M | -$8.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7.5M | $8.4M | $9.6M | $324K | $396K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $17.4M | $39.9M | $45.9M | $58.1M | $62.3M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $1.1M | -- | -- | -- | -- | |
Other Current Assets | -- | $2M | $2.3M | $2.1M | $2.6M | |
Total Current Assets | $26M | $50.3M | $57.8M | $60.6M | $75.1M | |
Property Plant And Equipment | $3.1M | $4.5M | $5M | $4M | $5.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $66.3M | $80.6M | $84.3M | $85.8M | $81.1M | |
Other Intangibles | $6.5M | $39.1M | $33.6M | $26.1M | $12.9M | |
Other Long-Term Assets | $293.3K | $1.1M | $901.7K | $635K | $683K | |
Total Assets | $102.2M | $175.7M | $181.5M | $177.1M | $175.6M | |
Accounts Payable | $12.5M | $26.4M | $28.7M | $38.6M | $37.1M | |
Accrued Expenses | $226.3K | $230.6K | $828.7K | $238K | $428K | |
Current Portion Of Long-Term Debt | $624.4K | $1.3M | $1.2M | $1.2M | $1.7M | |
Current Portion Of Capital Lease Obligations | $668K | $868.8K | $489.9K | $494K | $434K | |
Other Current Liabilities | -- | -- | -- | -- | $1.8M | |
Total Current Liabilities | $17.3M | $37.7M | $38.1M | $44.9M | $44.4M | |
Long-Term Debt | $14.9M | $62.4M | $70.6M | $64.6M | $76.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $34.2M | $102M | $110.4M | $110.8M | $121.5M | |
Common Stock | $18.4K | $19.1K | $19.7K | $20K | $21K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $68M | $73.6M | $71.1M | $66.3M | $54.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $68M | $73.6M | $71.1M | $66.3M | $54.2M | |
Total Liabilities and Equity | $102.2M | $175.7M | $181.5M | $177.1M | $175.6M | |
Cash and Short Terms | $7.5M | $8.4M | $9.6M | $324K | $396K | |
Total Debt | $15.6M | $63.7M | $71.7M | $65.8M | $77.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $10.8M | $7.9M | $9.8M | $581.1K | $1.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $20.7M | $46.6M | $43.6M | $60.4M | $64.2M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $1.2M | $2M | -- | -- | -- | |
Other Current Assets | -- | -- | $2.4M | $1.8M | $2.4M | |
Total Current Assets | $32.7M | $56.5M | $55.8M | $62.9M | $68M | |
Property Plant And Equipment | $2.9M | $4.3M | $4.7M | $5.6M | $6.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $66.3M | $81.2M | $84.3M | $85.8M | $81.1M | |
Other Intangibles | $6.2M | $39.7M | $31.5M | $24.1M | $10.3M | |
Other Long-Term Assets | $294.2K | $1.1M | $845.7K | $610.5K | -- | |
Total Assets | $108.4M | $182.8M | $177.1M | $179M | $165.7M | |
Accounts Payable | $17.1M | $31.7M | $30M | $36.3M | $39.9M | |
Accrued Expenses | $214K | $233.1K | $329.2K | $259.8K | $984K | |
Current Portion Of Long-Term Debt | $624.4K | $1.6M | $1.2M | $1.2M | $1.5M | |
Current Portion Of Capital Lease Obligations | $672.6K | $715.1K | $494.8K | $479.5K | $450K | |
Other Current Liabilities | $1.6M | -- | -- | -- | -- | |
Total Current Liabilities | $22.5M | $43.6M | $37.7M | $43M | $46.5M | |
Long-Term Debt | $14.3M | $65.7M | $68.3M | $68.5M | $74.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $38.7M | $111.1M | $107.6M | $112.7M | $121.3M | |
Common Stock | $18.7K | $19.1K | $19.7K | $20.2K | $21K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $69.8M | $71.7M | $69.5M | $66.3M | $44.4M | |
Total Liabilities and Equity | $108.4M | $182.8M | $177.1M | $179M | $165.7M | |
Cash and Short Terms | $10.8M | $7.9M | $9.8M | $581.1K | $1.4M | |
Total Debt | $14.9M | $67.4M | $69.5M | $69.6M | $75.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1M | $1.7M | -$6M | -$7.3M | -$15.1M | |
Depreciation & Amoritzation | $1.3M | $2.8M | $10M | $9.9M | $10.3M | |
Stock-Based Compensation | $1.5M | $1.4M | $1.3M | $1.3M | $1.6M | |
Change in Accounts Receivable | -$2.3M | -$11.7M | -$4.2M | -$13.7M | -$9.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3.1M | $2.6M | -$2.3M | -$1.4M | -$6.1M | |
Capital Expenditures | $506.1K | $636.2K | $1.7M | $1.9M | $6M | |
Cash Acquisitions | -- | -$16.3M | -$2.6M | -- | -- | |
Cash From Investing | -$506.1K | -$16.9M | -$4.3M | -$1.9M | -$6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $71.1M | $84.7M | $84.1M | $91.4M | $110.4M | |
Long-Term Debt Repaid | -$71.7M | -$70.1M | -$77M | -$98.5M | -$99M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.1M | -$37.5K | -$214.6K | -- | -$682K | |
Cash From Financing | $1.5M | $15.3M | $7.8M | -$6M | $12.1M | |
Beginning Cash (CF) | $3.4M | $7.5M | $8.4M | $9.6M | $324K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $4.1M | $911.6K | $1.1M | -$9.2M | $72K | |
Ending Cash (CF) | $7.5M | $8.4M | $9.6M | $324K | $396K | |
Levered Free Cash Flow | $2.6M | $1.9M | -$4M | -$3.3M | -$12.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.1M | -$2.2M | -$2M | -$655K | -$10.4M | |
Depreciation & Amoritzation | $475.7K | $2.4M | $2.5M | $2.5M | $1.7M | |
Stock-Based Compensation | $309.6K | $258.6K | $298.4K | $357K | $662K | |
Change in Accounts Receivable | -$3.3M | -$6.7M | $2.1M | -$2.9M | -$1.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $4M | -$391.6K | $3M | -$1.7M | -$1.1M | |
Capital Expenditures | $158.6K | $323K | $240.7K | $2.3M | $457K | |
Cash Acquisitions | -- | -$3.1M | -- | -- | -- | |
Cash From Investing | -$158.6K | -$3.5M | -$240.7K | -$2.3M | $4.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $13.4M | $18.6M | $17.1M | $27.5M | $27.9M | |
Long-Term Debt Repaid | -$14.2M | -$15.3M | -$19.6M | -$23.6M | -$30.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$45.8K | -- | -$100K | -- | |
Cash From Financing | -$557.3K | $3.3M | -$2.5M | $4.2M | -$2.5M | |
Beginning Cash (CF) | $7.5M | $8.4M | $9.6M | $324K | $396K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.2M | -$506.3K | $241.5K | $257K | $1M | |
Ending Cash (CF) | $10.8M | $7.9M | $9.8M | $581K | $1.4M | |
Levered Free Cash Flow | $3.8M | -$714.6K | $2.7M | -$3.9M | -$1.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.4M | -$1.6M | -$5.9M | -$5.9M | -$24.8M | |
Depreciation & Amoritzation | $1.4M | $4.7M | $10M | $9.9M | $9.5M | |
Stock-Based Compensation | $1.4M | $1.3M | $1.3M | $1.4M | $1.9M | |
Change in Accounts Receivable | -$4.3M | -$15M | $4.6M | -$18.6M | -$8.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $7.1M | -$1.8M | $1M | -$6M | -$5.5M | |
Capital Expenditures | $625.7K | $800.6K | $1.6M | $3.9M | $4.2M | |
Cash Acquisitions | -- | -$19.4M | $501.6K | -- | -- | |
Cash From Investing | -$625.7K | -$20.2M | -$1.1M | -$3.9M | $841K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $60.9M | $90M | $82.5M | $101.9M | $110.7M | |
Long-Term Debt Repaid | -$62.2M | -$71.1M | -$81.3M | -$102.5M | -$105.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $961.4K | $19.2M | $2M | $687.2K | $5.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $7.4M | -$2.8M | $1.9M | -$9.2M | $849K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $6.4M | -$2.6M | -$584.1K | -$9.9M | -$9.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.1M | -$2.2M | -$2M | -$655K | -$10.4M | |
Depreciation & Amoritzation | $475.7K | $2.4M | $2.5M | $2.5M | $1.7M | |
Stock-Based Compensation | $309.6K | $258.6K | $298.4K | $357K | $662K | |
Change in Accounts Receivable | -$3.3M | -$6.7M | $2.1M | -$2.9M | -$1.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $4M | -$391.6K | $3M | -$1.7M | -$1.1M | |
Capital Expenditures | $158.6K | $323K | $240.7K | $2.3M | $457K | |
Cash Acquisitions | -- | -$3.1M | -- | -- | -- | |
Cash From Investing | -$158.6K | -$3.5M | -$240.7K | -$2.3M | $4.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $13.4M | $18.6M | $17.1M | $27.5M | $27.9M | |
Long-Term Debt Repaid | -$14.2M | -$15.3M | -$19.6M | -$23.6M | -$30.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$45.8K | -- | -$100K | -- | |
Cash From Financing | -$557.3K | $3.3M | -$2.5M | $4.2M | -$2.5M | |
Beginning Cash (CF) | $7.5M | $8.4M | $9.6M | $324K | $396K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.2M | -$506.3K | $241.5K | $257K | $1M | |
Ending Cash (CF) | $10.8M | $7.9M | $9.8M | $581K | $1.4M | |
Levered Free Cash Flow | $3.8M | -$714.6K | $2.7M | -$3.9M | -$1.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.